Cellics Therapeutics, Inc., a biotechnology company pioneering Cellular Nanoparticle (CNP) platform technology for drug development and delivery, announced today that the company has appointed Paul Daruwala as the company’s president…
Cellics Therapeutics, Inc., a biotech startup company using the innovative Cellular Nanoparticle (CNP) Technology for the treatment and prevention of infectious and inflammatory diseases, announced today that the U.S. Food and…
Cellics announced today that it has received a CARB-X Award of up to US$15 Million to develop a new treatment for sepsis caused by drug-resistant Gram-positive and Gram-negative bacteria. The…
Cellics Therapeutics, Inc. (Cellics) announced today that results of the study that evaluates the potential benefits of macrophage and pulmonary epithelial nanosponges in neutralizing SARS-CoV-2 infectivity have been published in Nano…